Hamilton Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Hamilton Wealth's GILD Position: Q2 2026 in Review
Hamilton Wealth reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $525K and leaving 35,724 shares worth $4.51M. The position accounts for 0.83% of the portfolio, ranked #34.
Hamilton Wealth first reported a position in GILD in Q4 2019 and has held it in 22 quarters since. The position peaked at $6.37M in Q4 2024. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Hamilton Wealth held 35,724 shares of Gilead Sciences worth $4.51M as of Q2 2026.
- Hamilton Wealth sold 3,982 Gilead Sciences shares in Q2 2026, an estimated $525K.
- Gilead Sciences made up 0.83% of Hamilton Wealth's portfolio in Q2 2026, its #34 holding.
- Hamilton Wealth first reported a position in Gilead Sciences in Q4 2019 and has held it in 22 quarters since.
- Hamilton Wealth's Gilead Sciences position peaked at $6.37M in Q4 2024.
- 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.